Based on this, the pathogenesis of psoriasis involving the IFNα-TNFα-IL-23-IL-17 pathway suggests that the elevated levels of IFNα in severe psoriasis cases might be further increased by TNF inhibitors, potentially heightening the risk of autoantibody production. This evidence concerns the gene IL17A and psoriasis.